BJC Capital Advisors

The evolution of the biopharmaceutical industry has witnessed the disaggregation of the industry value chain.  Today, emerging companies in the sector may be best characterized as an outsourced R&D function for the large pharmaceutical companies, who leverage their established regulatory and commercialization engines to optimize externally sourced innovation. In such a scenario, the intrinsic value of infrastructure, both physical and intellectual, is often minimized and may arguably be considered detracting.  BJC Capital Advisors, a FINRA registered broker/dealer, was established to complement these sector trends with professional services designed to enhance capital efficiency and value realization.

FINRA BrokerCheck

Benjamin Conway - Founding Managing Director

​Benjamin Conway has over 25 years of experience in investment banking with transaction experience involving mergers & acquisitions, public and private equity financings and strategic partnerships across an array of sectors including biotechnology, specialty pharmaceuticals, medical device, diagnostics and the ancillary services sectors.  Prior to founding the firm, he was managing director and head of the life sciences practice at Boston-based Consilium Partners.  Previously, Ben was with Johnston Blakely & Company, a boutique life science investment bank he founded in 2002 which was subsequently acquired by Germany’s CMC Consulting. Ben was group head of biotechnology investment banking at Adams, Harkness & Hill, a Boston-based investment bank and his experience includes positions with Abbott Laboratories and Bain & Company.  Ben received an M.B.A., with honors, from the Harvard Business School and an A.B., magna cum laude, from Bowdoin College.  He holds FINRA Series 7, 24, 63, 79 and 28 licenses.

Michael J. Nowak, Ph.D. - Managing Director 

​Michael J. Nowak, Ph.D., with broad life science experience, leads BJC Captial Advisors' West Coast investment banking activities.  In addition to his background in investment banking, Dr. Nowak has held positions as a senior venture capitalist, healthcare institutional investor and serial entrepreneur. He served as General Partner in billion-dollar Euro-US venture fund TVM Capital based in Boston and was Managing Director with Yorkville Advisors, a billion-dollar global hedge fund based in New York where he managed the firm's healthcare  portfolio. He has held numerous CEO positions in early-stage startups, including spinouts from Xerox PARC and Stanford University. His experience also includes work at McKinsey & Company and the Advanced Technology Program at NIST, US Department of Commerce. Dr. Nowak earned an M.B.A from the Wharton School at the University of Pennsylvania and a PhD in Physics from the University of California, Santa Barbara.  He worked as a post-doctoral scientist at Bell Labs (Bellcore), Princeton University, and at the CEA research labs and the Sorbonne University in Paris. He received his B.A. in Physics from Cornell University in Ithaca, NY, where he was a College Scholar. He holds FINRA Series 79 and 63 licenses